Patent ID: 11883528
Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating congestive heart failure in a subject, the method comprising:
administering to the pulmonary tract of the subject a composition comprising an amount of triiodothyronine (T3) effective to ameliorate lung inflammation or pulmonary edema, wherein the composition comprises:
a salt of triiodothyronine in an amount effective to provide a lung-delivered dose of from 100 ng to 2 mg; and
a pharmaceutically acceptable buffer;
wherein the composition delivered to the lung has a pH from 5.5 to 8.5 and a maximum volume of no more than 0.30 ml per 1.67 g wet lung weight per dose.